Genetic testing for hereditary pheochromocytoma and PGL syndromes is largely based on published algorithms,[27] whereby testing is performed stepwise based on factors such as tumor type and location, age at diagnosis, family history, and presence of malignancy.[7,28,29] This approach has allowed for cost-effective, targeted testing based on clinical features.